StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

[2-[(Dichloracetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl]-[R-(R*,R*)]-hydrogensuccinat

Chloramphenicol succinate

HCID 656580
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
3544-94-3
Standard-SMILES
O=C(O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1
InChIKey
LIRCDOVJWUGTMW-ZWNOBZJWSA-N
Summenformel
C15H16Cl2N2O8
Durchschnittliche Molmasse
423,2 g/mol
Monoisotopische Masse
422,0283709

Überblick

Chloramphenicol succinate is a hemisuccinate and a member of amphetamines.

Namen und Bezeichner

Bevorzugter Name
Chloramphenicol succinate
IUPAC
4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acid
Lokaler Name
[2-[(Dichloracetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl]-[R-(R*,R*)]-hydrogensuccinat
Englischer Name
Chloramphenicol hemisuccinate
Summenformel
C15H16Cl2N2O8
Molmasse
423.2

Namen und Synonyme

CHLORAMPHENICOL SUCCINATE3544-94-3chloramphenicol hemisuccinateLevomycetin succinateChloramphenicol monosuccinateChloromycetin succinateZCX619U9A1NSC-756676DTXSID80481554-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxo-butanoic acid4-((2R,3R)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propoxy)-4-oxo-butanoic acidRefChem:125272
Weitere Namen anzeigen
Chloramphenicol 3-succinate
DTXCID4028129222-590-0Chronicin foam4-((2R,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propoxy)-4-oxobutanoic acid4-[(2R,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acidKemicetine succinateParaxin succinateLevomycetin hemisuccinate

Datenbank-Bezeichner

CAS
3544-94-3

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,1
Polarare Oberfläche (TPSA)
159 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
10
Schwere Atome
27
Formalladung
0
Komplexität
546

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15

Physikochemische Eigenschaften

Schmelzpunkt
127 °C · 127 °C
Siedepunkt
716.3 · 716.3±60.0 °C(Predicted)
Dichte
1.6769 · 1.6769 (rough estimate)
Brechungsindex
1.735 · 1.7350 (estimate)
storage temp.
-20 °C · Store at -20°C
Löslichkeit
DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble
Aggregatzustand
A solid
pka
4.36 · 4.36±0.17(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P308+P316, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationREACH registered substance: [2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hydrogen [R-(R*,R*)]-succinate (EC: 222-590-0)
Hazard Classes and CategoriesAcute Tox. 4 (66.7%)

Sicherheitsdaten

Alarmwort
Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302

Chemie und Industrie

Pharmakologische Informationen

Protein BindingChloramphenicol succinate is 57-92% protein bound in plasma.
Pharmacodynamics · 1 Eintrag

Chloramphenicol succinate is a prodrug of chloramphenicol, which binds to bacterial ribosomes and prevents translation. It has a narrow therapeutic index and a moderate duration of action. Patients should be counselled regarding the risk of serious fatal blood dyscrasias.

Mechanism of Action · 1 Eintrag

Chloramphenicol succinate is hydrolyzed into the active chloramphenicol. Chloramphenicol resembles uridine-5'-phosphate. It binds to the residues A2451 and A2452 in the 23S rRNA of the 50S ribosomal subunit of _E. coli_, which prevents translation.

Biological Half-LifeThe half life of chloramphenicol succinate in patients with normal renal and hepatic function is 0.6-2.7h.
Metabolism/Metabolites · 1 Eintrag

Chloramphenicol succinate is hydrolyzed to chloramphenicol. The propane-diol moiety of chloramphenicol can be metabolised through a number of pathways including glucuronidation, sulfate conjugation, phosphorylation, acetylation, and oxidation. The dichloroacetate moiety can be metabolised through hydrolysis of the amide group and dechlorination. The nitro functional group can also be metabolised to an aryl amine and aryl amide metabolite.

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and Excretion · 4 Einträge

Chloramphenicol succinate has a high degree of interpatient variability, with a Tmax of 18 minutes to 3 hours. A 1g oral chloramphenicol succinate dose every 6-8 hours reaches a mean Cmax of 11.2µg/mL with a Tmax of 1 hour.

6-80% of chloramphenicol succinate is eliminated unchanged in the urine, though this is highly variable between patients. On average, 30% of chloramphenicol succinate is eliminated unchanged in the urine and 10% is eliminated as the active chloramphenicol in the urine.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
PubChem CID
656580
DTXSID
DTXSID8048155
ChEMBL
CHEMBL1201281
ChEBI
CHEBI:3606
UNII
ZCX619U9A1
EC Number
222-590-0
Nikkaji
J186.557I

Chloramphenicol succinate has a volume of distribution of 0.2-3.1L/kg.

Chloramphenicol succinate's total clearance is 530-540mL/min in patients with normal renal and hepatic function, and 354mL/min in patients with renal or hepatic dysfunction. Chloramphenicol succinate's renal clearance is 222-260mL/min in patients with normal renal and hepatic function, and 66mL/min in patients with renal or hepatic dysfunction.

Anwendungen · 2 Einträge

BeschreibungChloramphenicol succinate is a water-soluble prodrug form of the antibiotic chloramphenicol. It is a substrate for succinate dehydrogenase (SDH) and is oxidized by human liver and rat liver and kidney mitochondria to release chloramphenicol in vitro. Chloramphenicol succinate reduces human leukocyte migration in vitro. In vivo, chloramphenicol succinate reduces E. coli growth in rabbit and rat models of pyelonephritis when administered at doses of 150 and 200 mg/kg, respectively. Chloramphenicol succinate (20 mg/kg) reduces infarct size in a porcine model of myocardial ischemia-reperfusion injury. Formulations containing chloramphenicol succinate have been used in the treatment of severe bacterial infections.

VerwendenChloramphenicol succinate is prepared by acylation of chloramphenicol with succinic anhydride to provide a water soluble pro-drug. Chloramphenicol succinate represents an alternative pro-drug strategy for chloramphenicol that has found a niche in surface antibiotic treatment in surgery. Chloramphenicol succinate is significantly less active than chloramphenicol but acts as a prodrug, forming chloramphenicol in the presence of succinate dehydrogenase.